GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $412,000 | -24.0% | 258,957 | -13.1% | 0.02% | -5.3% |
Q4 2021 | $542,000 | -48.1% | 297,947 | -20.5% | 0.02% | -42.4% |
Q3 2021 | $1,045,000 | -63.6% | 374,730 | -60.3% | 0.03% | -59.8% |
Q2 2021 | $2,872,000 | -31.0% | 944,631 | -22.2% | 0.08% | -32.8% |
Q1 2021 | $4,162,000 | -30.6% | 1,213,540 | -37.0% | 0.12% | -34.4% |
Q4 2020 | $5,993,000 | -18.1% | 1,926,899 | -7.0% | 0.19% | -17.0% |
Q3 2020 | $7,317,000 | -26.2% | 2,072,745 | 0.0% | 0.22% | -25.1% |
Q2 2020 | $9,908,000 | +119.6% | 2,072,745 | +59.0% | 0.30% | +76.9% |
Q1 2020 | $4,511,000 | -11.2% | 1,303,652 | +48.3% | 0.17% | +7.6% |
Q4 2019 | $5,082,000 | +20.9% | 879,200 | 0.0% | 0.16% | +0.6% |
Q3 2019 | $4,203,000 | -35.9% | 879,200 | 0.0% | 0.16% | -22.8% |
Q2 2019 | $6,559,000 | +1.0% | 879,200 | +10.6% | 0.20% | -0.5% |
Q1 2019 | $6,493,000 | +13.9% | 794,701 | -4.8% | 0.20% | +16.0% |
Q4 2018 | $5,699,000 | -50.0% | 834,401 | -0.5% | 0.18% | -42.8% |
Q3 2018 | $11,389,000 | +29.1% | 838,674 | +13.2% | 0.31% | -14.3% |
Q2 2018 | $8,819,000 | +413.0% | 741,108 | +140.1% | 0.36% | +363.6% |
Q1 2018 | $1,719,000 | -53.0% | 308,628 | -22.8% | 0.08% | -52.8% |
Q4 2017 | $3,660,000 | – | 400,000 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,347,755 | $574,818 | 0.02% |
Virtu Financial LLC | 31,633 | $13 | 0.00% |
Western Wealth Management, LLC | 29,537 | $12,597 | 0.00% |
Belpointe Asset Management LLC | 14,050 | $5,992 | 0.00% |
TSFG, LLC | 3,000 | $1 | 0.00% |
ZRC WEALTH MANAGEMENT, LLC | 100 | $43 | 0.00% |
Allworth Financial LP | 250 | $107 | 0.00% |
JANE STREET GROUP, LLC | 13,189 | $5,625 | 0.00% |
RAYMOND JAMES & ASSOCIATES | 138,040 | $58,874 | 0.00% |
BOURGEON CAPITAL MANAGEMENT LLC | 500 | $214 | 0.00% |